AU5402490A - Therapeutic compounds, compositions and uses thereof - Google Patents

Therapeutic compounds, compositions and uses thereof

Info

Publication number
AU5402490A
AU5402490A AU54024/90A AU5402490A AU5402490A AU 5402490 A AU5402490 A AU 5402490A AU 54024/90 A AU54024/90 A AU 54024/90A AU 5402490 A AU5402490 A AU 5402490A AU 5402490 A AU5402490 A AU 5402490A
Authority
AU
Australia
Prior art keywords
vasodilator
cgrp
nimodipine
calcium antagonist
blood supply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54024/90A
Other languages
English (en)
Inventor
Terence Bennett
Sheila Margaret Gardiner
Ursula Mary Ney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of AU5402490A publication Critical patent/AU5402490A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54024/90A 1989-04-10 1990-04-10 Therapeutic compounds, compositions and uses thereof Abandoned AU5402490A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908023A GB8908023D0 (en) 1989-04-10 1989-04-10 Therapeutic compounds,compositions and uses thereof
GB8908023 1989-04-10

Publications (1)

Publication Number Publication Date
AU5402490A true AU5402490A (en) 1990-11-05

Family

ID=10654739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54024/90A Abandoned AU5402490A (en) 1989-04-10 1990-04-10 Therapeutic compounds, compositions and uses thereof

Country Status (7)

Country Link
EP (1) EP0433402A1 (ko)
JP (1) JPH03505462A (ko)
KR (1) KR920700041A (ko)
AU (1) AU5402490A (ko)
CA (1) CA2014282A1 (ko)
GB (1) GB8908023D0 (ko)
WO (1) WO1990011769A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤

Also Published As

Publication number Publication date
EP0433402A1 (en) 1991-06-26
KR920700041A (ko) 1992-02-19
WO1990011769A1 (en) 1990-10-18
JPH03505462A (ja) 1991-11-28
GB8908023D0 (en) 1989-05-24
CA2014282A1 (en) 1990-10-10

Similar Documents

Publication Publication Date Title
US5985877A (en) Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
EP0309100B1 (en) Use of amylin or CGRP for the treatment of diabetes mellitus
AU2010241263B2 (en) Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering from Wasting
KR20010023331A (ko) 혈관신생 촉진제 및 혈관신생 작용증강제
KR0158870B1 (ko) 폐순환 승압의 치료, 예방 또는 진단용 조성물
UA63032C2 (en) Drug for treating hypertension
US6218411B1 (en) Therapeutics for diabetic complications
KR20000064939A (ko) 디하이드로피리딘화합물을함유하는안조직말초순환개선제
EP0911034A1 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
AU5402490A (en) Therapeutic compounds, compositions and uses thereof
JP4828670B2 (ja) 眼循環障害改善剤
US7214659B2 (en) Reduction of the electrocardiographic QT interval
US20040147566A1 (en) Lisinopril/lercanidipine combination therapy
US4298611A (en) Process for reducing blood pressure in animals
KR930001105B1 (ko) 심부정맥 예방 또는 치료용약제
KR970009076B1 (ko) 디하이드로피리딘 화합물을 함유하는 정맥 신전도 증진제 및 심장 비대 억제제
JP4243701B2 (ja) ベンズアミド誘導体を有効成分とするリウマチ治療薬
WO1990012815A1 (en) Therapeutic compounds, compositions and uses thereof
KR100356899B1 (ko) 궤양성 대장염 및/또는 크론병 예방 및 치료제
AU2557788A (en) Cgrp for cerebral blood supply improvement
WO1990001330A1 (en) Use of neuromedins u8 and u25 as therapeutic compounds
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
JP2004359675A (ja) 脳卒中の治療および予防剤
WO2004035051A1 (en) Lisinopril/lercanidipine combination therapy
JPH1072347A (ja) 眼血管血流改善剤